• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高钆基磁共振成像造影剂敏感性的策略。

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

作者信息

Caravan Peter

机构信息

EPIX Pharmaceuticals, 67 Rogers St, Cambridge, MA 02142, USA.

出版信息

Chem Soc Rev. 2006 Jun;35(6):512-23. doi: 10.1039/b510982p. Epub 2006 May 3.

DOI:10.1039/b510982p
PMID:16729145
Abstract

Gadolinium(III) complexes are often used in clinical MRI to increase contrast by selectively relaxing the water molecules near the complex. There is a desire to improve the sensitivity (relaxivity) of these contrast agents in order to detect molecular targets. This tutorial review describes the molecular factors that contribute to relaxivity and illustrates with recent examples how these can be optimized. It may be of interest to senior undergraduates and more advanced researchers interested in lanthanide chemistry, biophysics, and/or molecular imaging.

摘要

钆(III)配合物常用于临床磁共振成像(MRI),通过选择性地使配合物附近的水分子弛豫来增强对比度。人们希望提高这些造影剂的灵敏度(弛豫率)以检测分子靶点。本教程综述描述了影响弛豫率的分子因素,并通过近期实例说明如何对其进行优化。对于对镧系元素化学、生物物理学和/或分子成像感兴趣的高年级本科生和更资深的研究人员而言,本文可能会有所助益。

相似文献

1
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.提高钆基磁共振成像造影剂敏感性的策略。
Chem Soc Rev. 2006 Jun;35(6):512-23. doi: 10.1039/b510982p. Epub 2006 May 3.
2
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.高弛豫率磁共振成像造影剂:配位化学与医学成像的交汇点
Angew Chem Int Ed Engl. 2008;47(45):8568-80. doi: 10.1002/anie.200800212.
3
Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.树枝状钆配合物中高效的弛豫增强:中等分子量共轭物中的有效运动耦合
Chem Commun (Camb). 2005 Jan 28(4):474-6. doi: 10.1039/b413536a. Epub 2004 Dec 17.
4
Lanthanides in magnetic resonance imaging.磁共振成像中的镧系元素。
Chem Soc Rev. 2006 Jun;35(6):557-71. doi: 10.1039/b516376p. Epub 2006 May 2.
5
Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.推动基于镧系元素的磁共振成像(MRI)造影剂在分子成像应用中的灵敏度极限。
Acc Chem Res. 2009 Jul 21;42(7):822-31. doi: 10.1021/ar800192p.
6
A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.一种基于钆(Gd3+)的磁共振成像造影剂,利用受体诱导的磁化增强(RIME)现象对β-半乳糖苷酶活性敏感。
Chemistry. 2008;14(3):987-95. doi: 10.1002/chem.200700785.
7
Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.基于1,2-羟基吡啶酸钆(III)的配合物:迈向高弛豫率的磁共振成像造影剂
Inorg Chem. 2004 Sep 6;43(18):5492-4. doi: 10.1021/ic049028s.
8
Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.大分子磁共振成像造影剂中常见合成子[Gd(DTPA-bz-NH2)(H2O)]2-的两种非对映异构体的分离与表征:它们的水交换和异构化动力学
Inorg Chem. 2005 May 16;44(10):3561-8. doi: 10.1021/ic048645d.
9
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.蛋白质靶向钆基磁共振成像(MRI)造影剂:设计与作用机制
Acc Chem Res. 2009 Jul 21;42(7):851-62. doi: 10.1021/ar800220p.
10
Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.钆(III)配合物作为磁共振成像造影剂:配体设计与配合物性质
Dalton Trans. 2008 Jun 21(23):3027-47. doi: 10.1039/b719704g. Epub 2008 Mar 27.

引用本文的文献

1
Tailoring Image Contrast for Cellular Magnetic Resonance Imaging using Gadolinium Chelates and Superparamagnetic Iron Oxide Particles.使用钆螯合物和超顺磁性氧化铁颗粒定制细胞磁共振成像的图像对比度
Mol Imaging Biol. 2025 Aug 21. doi: 10.1007/s11307-025-02044-x.
2
Radiolabeled Nanogels: From Multimodality Imaging to Combination Therapy of Cancer.放射性标记的纳米凝胶:从多模态成像到癌症联合治疗
Small Sci. 2025 Jun 19;5(8):2400298. doi: 10.1002/smsc.202400298. eCollection 2025 Aug.
3
Ferrocene-Functionalized Black Phosphorus Nanoplatform Enables Targeted and Prolonged MRI Visualization of Atherosclerotic Plaques.
二茂铁功能化黑磷纳米平台实现动脉粥样硬化斑块的靶向和长效磁共振成像可视化
Adv Sci (Weinh). 2025 Aug;12(32):e03654. doi: 10.1002/advs.202503654. Epub 2025 Jun 5.
4
Comprehensive relaxometric analysis of Fe(iii) coordination polymer nanoparticles for -MRI: unravelling the impact of coating on contrast enhancement.用于磁共振成像的Fe(III)配位聚合物纳米颗粒的综合弛豫分析:揭示涂层对对比度增强的影响
Nanoscale Adv. 2025 May 9. doi: 10.1039/d5na00250h.
5
Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review.用于热疗、磁共振成像和药物递送应用的氧化铁基磁性纳米颗粒:综述
RSC Adv. 2025 Apr 14;15(15):11587-11616. doi: 10.1039/d5ra00728c. eCollection 2025 Apr 9.
6
PD-L1 blockade peptide-functionalized NaGdF nanodots for efficient magnetic resonance imaging-guided immunotherapy for breast cancer.用于乳腺癌高效磁共振成像引导免疫治疗的PD-L1阻断肽功能化的NaGdF纳米点
RSC Adv. 2025 Mar 25;15(12):9027-9033. doi: 10.1039/d4ra08800j. eCollection 2025 Mar 21.
7
Gadolinium-Based Contrast Agents (GBCAs) for MRI: A Benefit-Risk Balance Analysis from a Chemical, Biomedical, and Environmental Point of View.用于磁共振成像的钆基造影剂(GBCAs):从化学、生物医学和环境角度进行的效益-风险平衡分析
Glob Chall. 2025 Jan 23;9(3):2400269. doi: 10.1002/gch2.202400269. eCollection 2025 Mar.
8
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.脂质体纳米药物的进展:创新制剂、治疗应用及精准医学的未来方向
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
9
Gadopiclenol: A q = 2 Gadolinium-Based MRI Contrast Agent Combining High Stability and Efficacy.钆塞酸二钠:一种具有高稳定性和有效性的q = 2型钆基磁共振成像造影剂。
Invest Radiol. 2025 Mar 1;60(3):234-243. doi: 10.1097/RLI.0000000000001121. Epub 2024 Oct 9.
10
The role of responsive MRI probes in the past and the future of molecular imaging.响应性磁共振成像探针在分子成像的过去与未来中的作用。
Chem Sci. 2024 Nov 27;15(48):20122-20154. doi: 10.1039/d4sc04849k. eCollection 2024 Dec 11.